ReCode Therapeutics

women gender womens health International Womens Day

Biotech

Biotech leaders urge FDA to not restrict abortion pill access

The letter notes that there are "over a hundred peer-reviewed studies" demonstrating mifepristone's safety and efficacy.

Darren Incorvaia Jul 2, 2025 2:14pm

ReCode Shehnaaz Suliman Annalee Armstrong

ReCode CEO Shehnaaz Suliman eyes second half IPO opportunity

Jan 17, 2024 10:31am

A lightbulb in a yellow bowl of pennis

Bioluminescence enters biotech venture spotlight with $477M

Nov 1, 2023 7:00am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am

abortion uterus pregnancy pills

Women in biotech see Roe v. Wade ruling as a call to action

Jul 11, 2022 8:00am

genetic medicine Mrna dna

ReCode breaks the mold with $120M financing, Big Pharma backing

Jun 29, 2022 6:00am